← Leaderboards
Gregory Michael Laird
Johns Hopkins University
$6,747,824
Attributed
$10,022,170
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,022,170 · 11
By mechanism
U24$4,893,393 · 1
R43$2,345,262 · 7
R44$2,000,000 · 1
R24$755,300 · 1
F31$28,215 · 1
Top collaborators
- Albine Martin9 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ernesto Freire$9,451,207
- Richard Douglas Moore$80,558,192
- B Douglas Smith$682,425
- Douglas A Jabs$24,554,490
- Stuart A Grossman$19,009,302
Others in their field
Top investigators on “Immune System”
- Lawrence Corey · Fred Hutchinson Cancer Center$527,549,553
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$327,516,759
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$314,842,858
- Barton F Haynes · Duke University$254,474,833
- Judith S. Currier · University Of California Los Angeles$247,114,730
- Peter B. Gilbert · Fred Hutchinson Cancer Center$210,957,667
Research focus
Immune SystemHiv-1Acquired Immunodeficiency SyndromeAnti-Retroviral AgentsLeftCd4 Positive T LymphocytesRetroviridaeSuccessCellsAntiretroviral TherapyPharmaceutical PreparationsNational Institute Of Allergy And Infectious DiseaseInfectionSamplingUnited States National Institutes Of HealthDiagnosticPerformanceFrequenciesMemory Cd4 T LymphocyteMeasurementRestMolecularVirusProviruses
Grant awards (17)
Centralized Resource to Accurately Quantify Latent and Expressed HIVReservoirs$755,300
R24 · FY2025 · AI · contact PI
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs$749,588
U24 · FY2024 · AI · contact PI
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs$1,476,344
U24 · FY2023 · AI · contact PI
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs$1,167,880
U24 · FY2022 · AI · contact PI
IPDA for High-Priority HIV-1 Subtype C to Enable Global Eradication Trials$300,000
R43 · FY2022 · AI · contact PI
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs$749,588
U24 · FY2021 · AI · contact PI
HIV-1 EnvLRS: a scalable, sequence-based assay for in-depth assessment of HIV-1 bNAb resistance$300,000
R43 · FY2021 · AI · contact PI
IPDA for High-Priority HIV-1 Subtype C to Enable Global Eradication Trials$300,000
R43 · FY2021 · AI · contact PI
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs$749,993
U24 · FY2020 · AI · contact PI
Development of Intact Proviral DNA Assays for SIV and SHIV$300,000
R43 · FY2020 · AI · contact PI
A Novel Test to Measure Latent Virus in HIV-1 Infected Patients$1,000,000
R44 · FY2019 · AI · contact PI
A Novel Test to Measure Latent Virus in HIV-1 Infected Patients$1,000,000
R44 · FY2018 · AI · contact PI
Development of a quantitative assay for intact HIV DNA measures in tissue$300,000
R43 · FY2018 · AI · contact PI
Development of a next-generation quantitative viral outgrowth assay (QVOA) for the standardized measurement of the HIV-1 latent reservoir$297,200
R43 · FY2017 · AI · contact PI
Highly specific HIV-1 mRNA detection method with global subtype coverage to monitor latency reversal in patients$288,740
R43 · FY2017 · AI · contact PI
A Novel Test to Measure Latent Virus in HIV-1 Infected Patients$259,322
R43 · FY2016 · AI · contact PI
Ex vivo reversal of HIV-1 latency using PKC-agonist / HDAC inhibitor combinations$28,215
F31 · FY2015 · AI · contact PI